Technology News and Research

RSS

World's first personal facemask for SARS protection

Triosyn Corp., a developer of products aimed at protecting against microbial threats, announced today that tests conducted by Health Canada’s National Microbiology Laboratory show that Triosyn T-1000™ Series Respirators protect against Severe Acute Respiratory Syndrome (SARS).

21 Jul 2004

Test that is 100% effective in detection of early ovarian cancer

The journal Endocrine-Related Cancer has published work showing that scientists from the Clinical Proteomics Program of the US National Cancer Institute (NCI) have discovered a test that was 100% effective for detecting early ovarian cancer in their study.

21 Jul 2004

New grid device helps orthodontists accurately place and guide the newly approved mini-orthoscrews

The newly Food and Drug Administration - approved orthoscrew - so tiny it is dwarfed by a fingertip - is difficult to place between the narrow spaces of teeth roots and bone.

21 Jul 2004

Cancer Research Technology grants exclusive license to Genentech to patent portfolio of an oncology target

Cancer Research Technology announced today that it has entered into a license agreement granting Genentech, Inc. exclusive worldwide rights to its patent portfolio covering an oncology target discovered in the Molecular Oncology Laboratory (Oxford) of Cancer Research UK.

21 Jul 2004

3M and MicroDose Technologies Inc. team up to bring advanced electronic dry powder inhaler to market

3M and MicroDose Technologies Inc., a privately held drug delivery company based in Monmouth Junction, N.J., announced today that the two companies have entered into an exclusive co-development and joint marketing agreement.

20 Jul 2004

Russian scientists incorporate HIV antigen into a tomato

Russian scientists are currently creating a pleasant and harmless vaccine, and edible one at that. So far, they managed to incorporate the protein gene – HIV antigen in tomatoes. The research is supported by International Science and Technology Center.

19 Jul 2004

CancerVax may increase the survival of patients with advanced stage non-small-cell lung cancer

CancerVax Corporation has announced that its wholly owned subsidiaries, Tarcanta, Inc., and Tarcanta, Ltd. (Ireland), have obtained the exclusive rights to complete the clinical development of three specific active immunotherapeutic (SAI) product candidates that target the epidermal growth factor receptor (EGFR) signaling pathway for the treatment of cancer.

19 Jul 2004

Market research 'World RNAi Markets: Current and Future Outlook'

Gene silencing by RNAi has now been identified as a crucial technology for target validation and therapeutics. By targeting and interfering with messenger RNA (mRNA), RNAi technology blocks the expression of the proteins implicated in disease progression.

19 Jul 2004

Safer and improved technologies for detecting and treating scoliosis

Calgary researchers, healthcare providers and local patients are working together to develop a high-tech imaging system for detecting and treating of scoliosis – a mysterious spinal condition that affects about one out of every 200 people, especially children.

17 Jul 2004

First medical waste traceability testing in Asia Pacific

Kureha Environmental Engineering Co. Ltd., a leading waste management company in Japan, will begin verification tests on the traceability of medical waste using radio frequency identification (RFID) tags.

17 Jul 2004

New type of cryogenic catheter

A U.S. clinical study is just getting under way that, if successful, could lead to a non-surgical "cure" for the most common type of cardiac arrhythmia. The study is evaluating a new type of cryogenic catheter co-developed by the National Institute of Standards and Technology.

16 Jul 2004

Online database of AIDS-related protein structures

Researchers who are either developing drug treatments for AIDS or studying the virus that causes the disease have a new resource - an online database of AIDS-related protein structures just unveiled for public use by the National Institute of Standards and Technology.

16 Jul 2004

Funding improves the quality of the fish we eat

The quality of the fish that ends up in the shops, and eventually on our dining tables, is set to improve following a three and a half year research project into the monitoring techniques available to the fish processing industry.

15 Jul 2004

Effective treatment for soft tissue sarcoma (rhabdomyosarcoma)

Rhabdomyosarcoma is a highly malignant aggressive form of soft tissue cancer in children, the causes of which are currently unknown. Although the fibrous growths can be found all over the body they commonly develop around the head, neck, bladder and testes in young boys.

15 Jul 2004

Novel tool that can be used to visualize single neurons in living brain tissue

Carnegie Mellon University neuroscientist Alison Barth has developed the first tool to identify and study individual neurons activated in a living animal.

15 Jul 2004

Scientists determine structure of staph, anthrax enzyme

Researchers at the U.S. Department of Energy's Argonne National Laboratory and the University of Chicago have determined the crystal structure of sortase B, an enzyme found in the bacteria that cause staph and anthrax. While an antibiotic is probably five to seven years away, the structure could provide the first clue in developing a treatment for the infections.

15 Jul 2004

Animal bone implants that resemble natural bone

Study shows that in older age, myelin insulation breaks down, resulting in a decline in the speed and efficiency of our brain

UCLA neuroscientists using a new MRI analysis technique to examine myelin sheaths that insulate the brain's wiring report that as people age, neural connections that develop last degenerate first.

12 Jul 2004